Clinical Trial Update: Alirocumab in Patients With Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial update for alirocumab in patients after acute myocardial infarction, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Myocardial Infarction

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Myocardial Infarction, Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2019-09-06